Ostadrahimi et al. (2014) [32], in a randomized double-blind placebo-controlled trial involving 30 women with breast cancer undergoing chemotherapy, evaluated beta glucan supplementation (10 mg daily for 21 days) for its effects on white blood cell counts and serum levels of IL-4 and IL-12. This evidence concerns the gene IL4 and breast carcinoma.